Xtant Medical (XTNT) stock price, revenue, and financials

Xtant Medical market cap is $165.6 m, and annual revenue was $53.34 m in FY 2020
View Company

$165.6 M

XTNT Mkt cap, 19-Apr-2021

$53.3 M

Xtant Medical Revenue FY, 2020
Xtant Medical Gross profit (FY, 2020)34.4 M
Xtant Medical Gross profit margin (FY, 2020), %64.5%
Xtant Medical Net income (FY, 2020)-7 M
Xtant Medical EBIT (FY, 2020)-751 K
Xtant Medical Cash, 31-Dec-20202.3 M
Xtant Medical EV183.5 M

Xtant Medical Revenue

Xtant Medical revenue was $53.34 m in FY, 2020

Embed Graph

Xtant Medical Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

29.7m33.0m33.1m35.3m59.3m90.0m82.6m72.2m64.7m53.3m

Revenue growth, %

7%68%52%

Cost of goods sold

9.1m10.3m14.2m13.0m20.3m27.7m32.5m28.7m22.2m18.9m

Gross profit

20.5m22.6m18.9m22.3m39.1m62.3m50.1m43.5m42.5m34.4m

Gross profit Margin, %

69%69%57%63%66%69%61%60%66%64%

Sales and marketing expense

18.5m15.6m16.0m16.9m28.7m44.1m40.5m32.1m25.8m21.0m

R&D expense

1.4m2.5m3.4m2.4m1.7m932.0k657.0k

General and administrative expense

6.6m11.1m10.8m8.9m13.0m15.8m15.2m12.9m17.9m13.5m

Operating expense total

27.5m27.6m27.9m28.6m51.2m69.8m87.9m103.6m44.8m35.1m

Depreciation and amortization

755.4k377.5k271.7k3.8m4.9m5.5m4.1m58.0k

EBIT

(6.5m)(4.9m)(9.0m)(6.3m)(12.1m)(7.5m)(37.8m)(60.1m)(2.3m)(751.0k)

EBIT margin, %

(22%)(15%)(27%)(18%)(20%)(8%)(46%)(83%)(3%)(1%)

Interest expense

1.2m1.9m3.7m4.2m7.6m11.9m14.6m10.0m

Pre tax profit

(3.0m)(7.7m)(12.7m)(10.5m)(19.7m)(19.4m)(52.4m)(70.1m)(8.1m)(6.7m)

Income tax expense

(17.5m)50.4k(98.0k)296.0k

Net Income

(3.0m)(7.7m)(12.7m)(10.5m)(2.2m)(19.5m)(52.4m)(70.1m)(8.2m)(7.0m)

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

7.4m7.2m7.7m8.2m8.9m8.6m8.3m7.9m8.9m8.9m8.5m9.5m9.9m17.7m21.0m21.5m23.1m22.1m21.4m19.8m17.9m18.7m17.3m16.7m15.3m15.7m14.8m10.5m14.0m

Cost of goods sold

1.7m1.3m1.9m2.3m2.6m3.1m3.6m3.3m3.4m3.3m3.5m3.4m6.0m6.9m6.8m7.1m7.2m7.9m8.4m5.7m6.3m5.7m5.9m5.4m5.2m5.2m4.0m4.8m

Gross profit

5.6m5.9m5.8m5.9m6.3m5.5m4.7m4.6m5.5m5.6m6.0m6.5m11.7m14.1m14.7m16.0m14.9m13.5m11.4m12.2m12.5m11.5m10.8m9.9m10.5m9.6m6.6m9.2m

Gross profit Margin, %

76%82%76%72%71%64%57%58%62%63%63%66%66%67%69%69%68%63%57%68%67%67%65%65%67%65%62%66%

Sales and marketing expense

4.3m4.8m4.1m3.8m3.4m3.8m4.2m4.1m4.1m4.4m3.9m4.7m5.0m8.4m10.5m10.4m11.2m11.0m11.1m8.9m8.3m8.5m7.8m6.7m6.1m6.7m6.4m3.9m5.3m

R&D expense

254.6k322.3k378.3k433.6k291.2k794.5k899.6k783.9k928.9k698.6k640.0k504.2k414.0k418.0k347.0k262.0k210.0k203.0k245.0k111.0k176.0k

General and administrative expense

1.4m2.1m2.6m2.3m2.4m2.9m2.3m2.8m2.3m2.1m2.3m2.4m2.4m4.0m3.5m3.9m3.8m4.1m4.5m3.3m3.0m3.4m2.5m4.2m4.0m4.2m4.3m2.9m3.0m

Operating expense total

6.0m7.8m7.2m6.2m6.1m6.7m6.6m7.0m6.7m6.9m6.7m7.8m7.9m16.5m16.5m16.8m17.9m17.5m18.2m14.9m13.9m14.7m13.0m11.5m10.5m11.2m11.0m6.9m8.5m

Depreciation and amortization

157.0k213.2k119.1k97.9k75.1k82.4k58.8k124.1k100.7k1.5m1.2m1.2m1.3m1.3m1.5m1.4m1.0m1.0m1.0m159.0k146.0k137.0k

EBIT

(280.0k)(1.6m)(1.3m)(347.4k)212.7k(1.2m)(1.9m)(2.3m)(1.2m)(1.3m)(1.3m)(1.7m)(1.4m)(4.9m)(2.4m)(2.1m)(1.9m)(2.6m)(4.7m)(3.5m)(1.7m)(2.3m)(1.4m)(668.0k)(563.0k)(705.0k)(1.4m)(387.0k)760.0k

EBIT margin, %

(4%)(22%)(17%)(4%)2%(14%)(23%)(30%)(13%)(15%)(15%)(18%)(14%)(28%)(11%)(10%)(8%)(12%)(22%)(18%)(9%)(12%)(8%)(4%)(4%)(4%)(9%)(4%)5%

Interest expense

132.9k541.2k142.9k266.2k867.9k1.1m1.2m2.0m2.9m568.4k1.5m2.4m1.5m2.1m3.2m2.3m3.2m3.2m5.0m3.8m3.6m2.7m1.7m2.1m1.4m1.2m

Pre tax profit

(405.3k)(3.2m)(1.0m)730.5k(2.5m)(1.7m)(2.5m)(4.4m)(2.8m)(1.9m)(1.9m)(2.5m)(2.4m)(1.3m)

Income tax expense

(23.0k)22.0k23.0k22.0k23.0k23.0k

Net Income

(405.3k)(3.2m)(1.0m)730.5k(2.5m)(1.7m)(2.5m)(4.4m)(4.1m)(1.9m)(1.2m)(4.2m)(2.9m)(5.6m)(4.5m)(5.8m)(9.7m)(5.3m)(5.0m)(3.2m)(2.8m)(1.9m)(1.9m)(2.5m)(2.5m)(1.4m)

Xtant Medical Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

751.1k4.9m3.0m4.5m6.4m2.6m2.9m6.8m5.2m2.3m

Accounts Receivable

7.1m7.2m4.8m4.4m15.4m12.7m10.0m10.1m6.9m

Prepaid Expenses

289.3k353.3k574.9k654.1k985.5k1.7m589.0k784.0k736.0k

Inventories

8.5m13.1m10.8m9.6m22.7m22.2m17.3m16.1m21.4m

Current Assets

16.6m25.6m19.2m19.1m45.4m49.0m39.5m34.7m32.2m31.4m

PP&E

3.8m5.2m5.2m4.7m11.8m15.8m9.9m7.2m4.7m4.3m

Goodwill

728.6k728.6k41.5m41.5m41.5m3.2m3.2m3.2m

Total Assets

23.2m34.5m28.9m28.0m143.1m144.1m105.7m46.4m43.2m41.5m

Accounts Payable

2.7m4.0m2.8m3.9m9.4m10.5m9.3m6.5m2.2m2.3m

Short-term debt

1.6m45.1k219.7k112.6k35.1k244.8k365.5k426.0k394.0k17.2m

Current Liabilities

10.9m8.7m9.7m8.5m21.5m31.1m25.8m12.1m9.4m25.6m

Long-term debt

6.6m14.5m16.5m20.9m112.7m67.7m78.1m78.0m3.0m

Total Debt

8.3m14.5m47.7k21.0m244.8k365.5k426.0k78.4m20.2m

Total Liabilities

17.7m30.3m32.7m35.7m134.2m151.2m164.4m90.2m87.4m27.0m

Common Stock

40.043.053.07.011.02.0

Preferred Stock

Additional Paid-in Capital

45.5m51.9m56.5m63.1m81.9m85.5m86.2m171.3m179.1m244.9m

Retained Earnings

(40.0m)(47.7m)(60.4m)(70.9m)(73.0m)(92.5m)(144.9m)(215.0m)(223.3m)(230.3m)

Total Equity

5.5m4.2m(3.8m)(7.8m)8.9m(7.1m)(58.7m)(43.8m)(44.2m)14.5m

Debt to Equity Ratio

1.5 x3.4 x0 x-2.7 x0 x0 x0 x

Debt to Assets Ratio

0.4 x0.4 x0 x0.8 x0 x0 x0 x

Financial Leverage

4.2 x8.2 x-7.5 x-3.6 x16.1 x-20.4 x-1.8 x-1.1 x-1 x2.9 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

1.4m1.8m1.4m1.2m8.6m2.1m5.1m3.4m4.8m3.0m7.0m2.9m2.0m8.0m4.7m2.2m1.4m2.5m1.7m2.1m6.2m6.0m5.1m7.1m7.3m5.7m3.2m3.0m2.7m

Accounts Receivable

5.5m6.4m7.6m6.6m7.2m7.2m6.2m4.6m5.5m4.9m4.3m5.5m5.6m13.3m14.9m14.7m15.8m16.3m15.8m13.9m10.3m10.4m9.9m9.5m8.6m9.1m9.7m7.6m7.3m

Prepaid Expenses

480.2k410.6k421.3k586.0k630.4k742.8k667.9k486.7k981.5k1.0m808.2k885.4k1.0m1.0m858.4k1.3m2.0m1.7m831.2k664.6k1.1m801.0k738.0k464.0k592.0k714.0k1.1m899.0k1.7m

Inventories

6.4m7.7m10.4m12.3m13.4m13.6m13.8m13.2m10.5m10.5m11.1m9.7m9.4m22.0m24.2m25.5m26.5m26.4m24.9m24.0m22.5m22.4m22.2m16.5m15.8m16.0m18.0m19.9m20.7m

Current Assets

14.5m17.0m19.8m20.7m29.8m23.6m25.8m21.8m21.8m19.4m23.2m19.0m18.0m44.4m44.7m43.7m45.8m46.8m43.3m40.7m40.1m39.7m37.9m33.6m32.3m31.6m32.1m31.4m32.4m

PP&E

3.4m3.5m4.1m4.5m4.9m5.5m5.5m5.3m5.0m4.9m4.8m4.5m4.4m11.4m13.8m15.6m16.0m14.6m13.4m11.5m9.3m8.9m8.1m6.4m5.6m5.1m4.3m4.3m4.1m

Goodwill

728.6k728.6k728.6k728.6k728.6k728.6k728.6k24.0m41.5m41.5m41.5m41.5m41.5m41.5m41.5m41.5m41.5m3.2m3.2m3.2m3.2m3.2m3.2m

Total Assets

19.8m23.4m26.7m28.5m38.4m32.7m35.1m31.0m31.2m28.4m31.8m27.4m26.4m126.2m141.4m141.3m142.4m139.1m133.7m128.5m104.8m102.8m99.3m47.1m44.5m43.0m42.6m41.7m42.4m

Accounts Payable

2.5m2.2m3.9m3.6m4.1m4.0m4.2m3.2m4.2m4.2m3.9m4.4m4.6m7.5m12.4m12.8m12.9m8.9m8.4m7.4m7.5m7.5m5.9m6.0m3.2m2.2m3.6m3.1m2.8m

Short-term debt

907.1k1.1m2.3m4.3m44.5k45.6k46.3k212.9k218.7k195.9k159.2k82.5k95.1k100.4k30.2k5.7m8.6m10.6m302.1k65.9m383.0k469.0k478.0k73.0m337.0k229.0k401.0k408.0k415.0k

Current Liabilities

6.5m7.5m11.5m11.8m8.8m8.4m9.5m8.9m11.6m9.8m9.4m10.4m10.3m16.7m25.6m25.6m28.5m28.9m20.8m87.2m12.0m12.4m10.4m11.3m9.9m9.1m10.1m9.5m9.3m

Long-term debt

4.3m7.1m6.0m6.4m14.2m14.7m15.3m16.2m19.7m20.1m20.5m21.3m21.7m112.3m112.4m116.2m119.1m51.8m64.0m71.4m77.2m79.8m76.2m75.0m75.6m76.8m79.0m79.0m81.0m

Total Debt

5.2m8.2m8.3m10.6m14.3m14.8m15.4m47.0k48.4k49.2k49.9k21.4m52.4k53.2k30.2k203.6k209.8k259.0k302.1k319.1k383.0k469.0k478.0k148.0m76.0m77.0m79.4m79.5m81.5m

Total Liabilities

10.8m14.7m17.7m18.3m29.9m30.1m31.7m31.7m37.8m36.4m36.3m37.9m38.2m129.1m138.0m141.8m147.5m151.4m155.6m158.7m89.2m92.2m86.6m86.2m85.6m85.9m89.0m88.5m90.4m

Common Stock

38.040.043.043.043.043.052.052.055.06.07.07.07.011.011.011.011.018.018.018.0

Preferred Stock

Additional Paid-in Capital

41.4m44.3m50.0m50.4m51.4m52.0m55.3m55.6m57.9m58.4m63.1m64.6m66.1m81.8m82.0m82.6m82.9m86.0m86.1m86.3m165.8m165.8m171.0m178.7m178.7m178.8m179.3m181.4m181.6m

Retained Earnings

(32.4m)(35.6m)(41.0m)(40.3m)(42.8m)(49.3m)(51.8m)(56.2m)(64.5m)(66.4m)(67.6m)(75.0m)(77.9m)(84.6m)(78.6m)(83.1m)(88.0m)(98.3m)(108.0m)(116.5m)(150.2m)(155.5m)(158.4m)(217.8m)(219.8m)(221.7m)(225.8m)(228.3m)(229.6m)

Total Equity

9.0m8.7m9.0m10.1m8.6m2.7m3.4m(636.0k)(6.6m)(8.0m)(4.5m)(10.5m)(11.8m)(2.8m)3.4m(496.3k)(5.1m)(12.3m)(21.9m)(30.2m)15.6m10.6m12.7m(39.2m)(41.1m)(42.9m)(46.5m)(46.9m)(48.0m)

Debt to Equity Ratio

0.6 x0.9 x0.9 x1 x1.7 x5.6 x4.5 x-0.1 x0 x0 x0 x-2 x0 x0 x0 x-0.4 x0 x0 x0 x0 x0 x0 x0 x-3.8 x-1.8 x

Debt to Assets Ratio

0.3 x0.4 x0.3 x0.4 x0.4 x0.5 x0.4 x0 x0 x0 x0 x0.8 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x3.1 x1.7 x

Financial Leverage

2.2 x2.7 x3 x2.8 x4.5 x12.3 x10.2 x-48.8 x-4.8 x-3.6 x-7.1 x-2.6 x-2.2 x-44.6 x42.1 x-284.7 x-27.9 x-11.3 x-6.1 x-4.2 x6.7 x9.7 x7.8 x-1.2 x-1.1 x-1 x-0.9 x-0.9 x-0.9 x

Xtant Medical Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(3.0m)(7.7m)(12.7m)(10.5m)(2.2m)(19.5m)(52.4m)(70.1m)(8.2m)(7.0m)

Depreciation and Amortization

755.4k782.9k753.5k952.3k4.9m7.2m8.4m6.6m3.1m2.1m

Accounts Receivable

(4.6m)(414.9k)797.7k283.6k(5.5m)(2.7m)4.7m2.5m(647.0k)2.9m

Inventories

(2.4m)(5.3m)747.7k(17.4k)(545.7k)(4.1m)2.1m40.0k692.0k(5.8m)

Accounts Payable

334.2k1.2m(1.0m)715.7k644.1k319.1k(1.6m)(3.0m)(4.3m)101.0k

Cash From Operating Activities

(7.4m)(10.8m)(5.6m)(7.3m)(9.1m)(14.4m)(543.2k)1.2m(413.0k)(731.0k)

Purchases of PP&E

(962.3k)(1.8m)(623.0k)(300.0k)(2.3m)(5.8m)(1.6m)(624.0k)(879.0k)(1.5m)

Cash From Investing Activities

(1.0m)(1.8m)35.3k(298.4k)(73.6m)(5.8m)(1.6m)(367.0k)(544.0k)(1.3m)

Long-term Borrowings

(5.1m)(9.8m)(771.7k)(825.4k)(1.4m)(144.6k)(88.2k)(359.0k)(455.0k)(471.0k)

Cash From Financing Activities

8.8m16.8m3.7m9.0m84.6m16.4m2.4m3.1m(603.0k)(861.0k)

Net Change in Cash

423.6k4.2m(1.9m)1.4m1.9m(3.8m)277.7k3.9m(1.6m)(2.9m)

Interest Paid

1.9m

Income Taxes Paid

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

4.5m1.3m(1.0m)(316.3k)(2.8m)(1.7m)(4.2m)(8.5m)(4.1m)(6.0m)(7.2m)(4.2m)(7.1m)(13.8m)(5.6m)(10.1m)(15.0m)(5.8m)(15.5m)(24.0m)(5.3m)(10.3m)(13.4m)(2.8m)(4.7m)(6.6m)(2.5m)(5.0m)(6.3m)

Depreciation and Amortization

590.1k803.3k213.5k403.3k577.1k200.4k394.8k586.8k169.1k345.6k498.3k235.1k446.8k2.4m1.8m3.6m5.6m2.1m4.2m7.4m1.6m3.2m7.5m776.0k1.6m2.3m685.0k1.2m1.7m

Accounts Receivable

(1.9m)(2.9m)(525.7k)524.2k(237.8k)(106.9k)156.3k971.0k(836.6k)(220.5k)346.2k(993.8k)(1.1m)(2.8m)328.3k207.9k(859.0k)2.5m2.5m4.1m2.3m2.2m2.8m403.0k1.4m417.0k195.0k2.3m2.5m

Inventories

(883.2k)(1.5m)(2.0m)(3.9m)(5.1m)(455.8k)(148.9k)265.4k238.6k306.9k(350.2k)147.7k209.8k477.8k(1.1m)(2.7m)(4.0m)261.2k1.2m1.7m(182.0k)(388.0k)(508.0k)623.0k955.0k760.0k(2.0m)(4.2m)(5.0m)

Accounts Payable

(353.8k)(200.0k)1.3m1.0m1.3m(145.0k)307.8k(636.0k)1.4m1.0m884.4k610.7k742.8k694.3k3.7m3.7m3.2m(1.7m)(2.4m)(3.4m)(1.9m)(1.9m)(3.6m)(429.0k)(3.5m)(4.2m)1.4m884.0k626.0k

Cash From Operating Activities

(4.4m)(6.4m)(2.9m)(4.9m)(7.8m)(2.3m)(3.6m)(5.2m)(2.2m)(3.9m)(5.2m)(2.1m)(4.1m)(9.0m)1.0m(7.8m)(11.2m)436.2k(756.7k)(1.2m)236.0k344.0k(779.0k)490.0k954.0k(342.0k)(1.8m)(1.6m)(1.6m)

Purchases of PP&E

(269.4k)(549.3k)(347.7k)(870.6k)(1.2m)(477.8k)(579.9k)(633.4k)(54.9k)(115.2k)(190.6k)(48.8k)(70.4k)(444.3k)(2.7m)(4.4m)(5.6m)(310.1k)(1.1m)(1.5m)(132.0k)(288.0k)(308.0k)(137.0k)(211.0k)(403.0k)(258.0k)(673.0k)(907.0k)

Cash From Investing Activities

(377.5k)(599.0k)(347.7k)(870.6k)(1.2m)(477.8k)(590.1k)(643.5k)(18.9k)(79.1k)(180.5k)(32.4k)(54.0k)(73.4m)(2.7m)(4.4m)(5.6m)(310.1k)(1.1m)(1.5m)(132.0k)(288.0k)(57.0k)(86.0k)(48.0k)(162.0k)(175.0k)(567.0k)(734.0k)

Short-term Borrowings

(154.6k)(10.4m)(10.4m)

Long-term Borrowings

(86.2k)(5.1m)(10.7k)(445.5k)(9.8m)(12.0k)(22.9k)(144.4k)(70.0k)(107.2k)(619.4k)(208.0k)(90.2k)(117.2k)(8.0k)(49.4k)(80.1k)(63.0k)(27.9k)(203.4k)(79.0k)(167.0k)(260.0k)(104.0k)(277.0k)(395.0k)(34.0k)(75.0k)(115.0k)

Cash From Financing Activities

5.9m8.5m3.9m6.2m16.9m(47.6k)4.4m4.3m3.9m3.9m9.3m542.0k1.7m85.8m(8.0k)8.0m11.8m(217.6k)910.9k2.1m3.2m3.1m3.0m(104.0k)(385.0k)(544.0k)(34.0k)(75.0k)(115.0k)

Net Change in Cash

1.1m1.5m612.5k462.5k7.9m(2.8m)209.9k(1.5m)1.7m(56.9k)3.9m(1.6m)(2.4m)3.4m(1.7m)(4.2m)(5.0m)(91.4k)(913.7k)(509.2k)3.3m3.2m2.2m300.0k521.0k(1.0m)(2.0m)(2.2m)(2.5m)

Interest Paid

483.3k815.0k1.9m2.2m

Income Taxes Paid

Xtant Medical Ratios

USDQ2, 2011

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x

Xtant Medical Employee Rating

2.517 votes
Culture & Values
2.5
Work/Life Balance
2.9
Senior Management
1.9
Salary & Benefits
2.4
Career Opportunities
2.3
Source
View Xtant Medical profile

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more